The severe shortage of ethically sourced human bodies poses a significant challenge in medicine. Over 100,000 patients in the US are currently waiting for a solid organ transplant. This scarcity also drives reliance on animal testing, which often fails to accurately replicate human physiology. Clinical trials, necessary for drug approval, have a success rate of less than 15% and can last over a decade. Recent biotechnology advances suggest a potential solution: “bodyoids.” These are living human bodies developed from pluripotent stem cells, lacking neural components for consciousness or pain. Bodyoids could provide an almost unlimited source of organs, tissues, and cells for transplantation. They might also enable personalized drug screening and eliminate the need for lifelong immunosuppression by using a patient’s own cells. While the concept faces technical and ethical hurdles, it promises to revolutionize medical research and reduce animal testing.
Source: www.technologyreview.com









